Sidiqi, M. Hasib
Aljama, Mohammed
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Jevremovic, Dragan
Buadi, Francis K.
Warsame, Rahma
Lacy, Martha Q.
Dingli, David
Gonsalves, Wilson I.
Fonder, Amie L.
Hobbs, Miriam A.
Hwa, Yi Lisa
Kapoor, Prashant
Kourelis, Taxiarchis
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Lust, John A.
Kyle, Robert A.
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Rajkumar, Vincent S. http://orcid.org/0000-0002-5862-1833
Gertz, Morie A.
Dispenzieri, Angela
Article History
Received: 3 October 2019
Revised: 4 February 2020
Accepted: 17 April 2020
First Online: 6 May 2020
Conflict of interest
: A.D. received research funding from Celgene, Millennium, Pfizer, and Janssen, and travel grant from Pfizer. M.A.G. received consultancy from Millenium and honoraria from Celgene, Millennium, Onyx, Novartis, SmithKline, Prothena, Ionis, and Amgen. S.K.K. received consultancy from Celgene, Millennium, Onyx, Janssen, and BMS, and research funding from Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS. M.Q.L. received research funding from Celgene. D.D. received research funding from Karyopharm Therapeutics, Amgen, and Millennium Pharmaceuticals. P.K. received research funding from Takeda, Celgene, and Amgen. The remaining authors declare no competing financial interests.